CSIMarket Company Name, Ticker, Competitors, else..


Illumina Inc   (NASDAQ: ILMN)
Other Ticker:  
 

Illumina Inc

ILMN's Fundamental analysis



Illumina Inc 's sales fell by -3.25 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 2499

Laboratory Analytical Instruments industry recorded deterioration of revenues by -1.06 %

Illumina Inc realized net income compared to net loss a year ago in first quarter of 2025

• More on ILMN's Growth


Illumina Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3098.59 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
11.06
PE TTM    
Company's Price to Sales ratio is at 3.57.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.35.


• More on ILMN's Valuation
 
 Total Debt (Millions $) 1,990
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 468,865
 Net Income/Employee (TTM) $ -104,432
 Receivable Turnover (TTM) 6.25
 Tangible Book Value (Per Share $) 6.14

Illumina Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3098.59 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
11.06
PE TTM    
Company's Price to Sales ratio is at 3.57.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.35.

Illumina Inc Price to Book Ratio is at 6.54 lower than Industry Avg. of 238.44. and higher than S&P 500 Avg. of 0.01

• More on ILMN's Valuation

•  Market Capitalization (Millions $) 15,493
•  Shares Outstanding (Millions) 159
•  Employees 9,250
•  Revenues (TTM) (Millions $) 4,337
•  Net Income (TTM) (Millions $) -966
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -124
•  Total Debt (Millions $) 1,990
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 468,865
•  Net Income/Employee(TTM) $ -104,432
•  Receivable Turnover Ratio (TTM) 6.25
•  Tangible Book Value (Per Share $) 6.14

•  Market Capitalization (Millions $) 15,493
•  Shares Outstanding (Millions) 159
•  Employees 9,250
•  Revenues (TTM) (Millions $) 4,337
•  Net Income (TTM) (Millions $) -966
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -124


    ILMN's Profitability Comparisons
Illumina Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 15.75 % from 15.76 % in IV. Quarter.

Illumina Inc net profit margin of 12.58 % is currently ranking no. 4 in Laboratory Analytical Instruments industry, ranking no. 85 in Healthcare sector and number 1064 in S&P 500.


Profitability by Segment
Total 12.58 %



  Ratio
•   Capital Ratio (MRQ) 1.86
•  Total Debt to Equity (MRQ) 0.84
•  Tangible Leverage Ratio (MRQ) 3
•  Asset Turnover Ratio (TTM) 0.85
•  Inventory Turnover Ratio (TTM) 2.63



Illumina Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 15.75 % from 15.76 % in IV. Quarter.

Illumina Inc net profit margin of 12.58 % is currently ranking no. 4 in Laboratory Analytical Instruments industry, ranking no. 85 in Healthcare sector and number 1064 in S&P 500.

• More on ILMN's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com